Adjuvant hormonal therapy significantly improves long-term survival of breast cancer
patients with hormone receptor-positive disease. Despite the proven clinical efficacy of …

Given the recent significant increase in the use of oral therapies in cancer management, an
understanding of patients' adherence to and persistence with oral therapy is crucial …

Despite the benefit of adjuvant hormonal therapy (HT) on mortality among women with
breast cancer (BC), many women are non-adherent with its use. We investigated the effects …

Purpose While studies have found that adjuvant hormonal therapy for hormone-sensitive
breast cancer (BC) dramatically reduces recurrence and mortality, adherence to medications …

Purpose To investigate adherence to endocrine treatment and its relationship with disease-
free survival (DFS) in the Breast International Group (BIG) 1-98 clinical trial. Methods The …

Purpose Noncompliance with adjuvant hormonal therapy among women with breast cancer
is common. Little is known about the impact of financial factors, such as co-payments, on …

Racial disparities in breast cancer mortality have been widely documented for several
decades and persist despite advances in receipt of mammography across racial groups …

Abstract Background Hormone Therapy (HT) reduces the risk of breast cancer recurrence
and mortality in women with breast cancer. Despite these clinical benefits, rates of HT non …

Purpose Previous research evaluating adherence to tamoxifen therapy among women with
early-stage breast cancer has revealed adherence estimates ranging from 25% to 96%. No …

Background Cancer is a disease that mostly affects older adults. Treatment adherence is
crucial to obtain optimal outcomes such as cure or improvement in quality of life. Older …